G. Storm

Biomaterials · 2004–2018

A researcher in the Science corpus: 6 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom G. Storm trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Vladimir Torchilin

Who trusts G. Storm overall

  1. R. Juliano

Papers from G. Storm's perspective

Ordered by how strongly the researchers G. Storm trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
  2. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
  3. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (Proceedings of the National Academy of Sciences of the United States of America)
  4. Challenges and key considerations of the enhanced permeability and retention (EPR) effect for nanomedicine drug delivery in oncology (Cancer Research)
  5. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. (Journal of Controlled Release)
  6. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. (Clinical Cancer Research)
  7. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. (Journal of Clinical Oncology)
  8. Structure and design of polymeric surfactant-based drug delivery systems. (Journal of Controlled Release)
  9. The hallmarks of cancer (RNA Biology)
  10. High interstitial fluid pressure — an obstacle in cancer therapy (Nature Reviews. Cancer)

Their papers